Jupiter Life Line Hospitals Ltd (JLHL) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Jupiter Life Line Hospitals reported strong quarterly and nine-month results for FY25, demonstrating consistent growth in key financial and operational metrics.
- Revenue for the quarter increased by 17.7% YoY, reaching Rs. 322 crores, driven by increased patient volumes and improved case mix.
- EBITDA for the quarter grew by 21.5% YoY to Rs. 76.4 crores, with a margin of 23.7%, reflecting operational efficiency and cost management.
- Nine-month revenue reached Rs. 934.8 crores, a 19.5% YoY increase, while EBITDA grew by 22% to Rs. 218.3 crores, maintaining a healthy margin of 23.4%.
- The company's expansion plans are progressing well, with the acquisition of land for a new hospital in Mira Road and regulatory approvals received for the second Pune hospital.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.